2001

Heart Failure Technology Deemed Fileable on an Expedited Basis Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implant of the CONTAK...

Grant to AHA will Empower Americans with Comprehensive Knowledge About Cardiovascular Disease and Heart Failure Indianapolis, Ind. - The Guidant Foundation today announced that it has presented a...

Field Action Results in One-Time Charge to First Quarter Earnings Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology,...

Sales Reach $671 million and Generate Adjusted Earnings per share of $0.41 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment of cardiac...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that it intends to repurchase up to $200 million of its common shares...

Guidant to Apply for New Indication Based on Study Results Indianapolis, IN, and St. Paul, MN - Results of the first clinical study to demonstrate that implantable cardioverter defibrillators...

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its first quarter 2001 earnings conference call on...

New System Allows Physicians to Treat Wider Range of Coronary Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced revenue of $671 million and adjusted earnings of $126.9 million for...

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - In an effort to equip the next...